STSP-0902 injection

DRUG2 trials

Sponsors

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Conditions

AsthenozoospermiaOligozoospermia

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects

CompletedNCT06563713

Staidson (Beijing) Biopharmaceuticals Co., LtdAsthenozoospermia, Oligozoospermia

Start: 2024-07-31End: 2025-02-24Updated: 2025-05-11

A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects

RecruitingNCT06948799

Staidson (Beijing) Biopharmaceuticals Co., LtdOligozoospermia

Start: 2025-05-08End: 2026-08-01Target: 64Updated: 2026-05-22